Oral miltefosine (MF) achieves per-protocol cure rates of 68–77% against Leishmania tropica in Iran and Pakistan, but it has never been compared with the standard of care in Afghanistan, where only intralesional (IL) or intramuscular (IM) antimonials are used. We, therefore, assessed the 6-month efficacy and tolerabili...
Bilal Ahmad Rahimi, W. Disphanurat, Khoshal Bakhtialy et al.· Tropical Medicine and Health· 0 citations
Background: Cutaneous leishmaniasis (CL) remains a major neglected tropical disease in Afghanistan; however, recent nationwide evidence on its geographical and temporal distribution is limited. This study assessed the reported burden, spatial distribution and seasonal variation of cutaneous leishmaniasis across Afghani...
Bilal Ahmad Rahimi, W. M. Lali, A. Sherzad et al.· medRxiv· 0 citations
It is indicated that greater clinical severity and respiratory compromise are associated with increased mortality risk, underscoring the value of early recognition of high-risk patients to guide timely management.
Y. Çağ, H. Caskurlu, H. Ankarali et al.· Mycopathologia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.